Dublin, Ohio-based Cardinal Health, Inc. (CAH) manufactures and distributes pharmaceuticals, medical & laboratory products, ...
Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.
Cardinal Health Inc. closed 4.35% short of its 52-week high of $132.84, which the company achieved on January 30th.
Argus analyst Kristina Ruggeri raised the firm’s price target on Cardinal Health (CAH) to $148 from $145 and keeps a Buy rating on the shares.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback